MEDIFAST (MED)
(Real Time Quote from BATS)
$24.10 USD
-0.90 (-3.60%)
Updated May 20, 2024 02:58 PM ET
5-Strong Sell of 5 5
A Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MED 24.10 -0.90(-3.60%)
Will MED be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Other News for MED
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
Readers Identify 23 Ideal April Dividend Buys
KXI: Consumer Staples Dashboard For May
(MED) - Analyzing Medifast's Short Interest
Pocket-Sized Powerhouses: 7 Small-Cap Value Stocks Ready to Roar